A Study of Trastuzumab Emtansine (Trastuzumab-MCC-DM1) Administered Intravenously to Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer
Public ClinicalTrials.gov record NCT00509769. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Single-arm, Open-label Study of Trastuzumab-MCC-DM1 Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer Who Have Progressed While Receiving HER2-Directed Therapy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This was a multi-institutional, open-label, single-arm, Phase II study of trastuzumab emtansine (T-DM1) administered by intravenous (IV) infusion to patients with human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer (MBC).
Study identification
- NCT ID
- NCT00509769
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 112 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 2007 (Type not available)
- Primary completion
- Jan 2009 (Actual)
- Completion
- Jun 2009 (Actual)
- Last update posted
- Apr 2, 2013
2007 – 2009
United States locations
- U.S. sites
- 40
- U.S. states
- 18
- U.S. cities
- 37
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Little Rock Hem Onc Assoc | Little Rock | Arkansas | 72205 | — |
| Rocky Mountain Cancer Center | Denver | Colorado | 80220 | — |
| Washington Cancer Institute | Washington D.C. | District of Columbia | 20010 | — |
| Lynn Cancer Institute - West | Boca Raton | Florida | 33428 | — |
| Florida Cancer Care | Davie | Florida | 33328 | — |
| Mayo Clinic | Jacksonville | Florida | 32224 | — |
| Hem/Onc Assoc - Treasure Coast | Port Saint Lucie | Florida | 34952 | — |
| Gulfcoast Oncology Associates | St. Petersburg | Florida | 33705 | — |
| Bay Area Oncology | Tampa | Florida | 33607 | — |
| Northwest Georgia Onc Ctrs PC | Marietta | Georgia | 30060 | — |
| John McClean, M.D. - Private P | Galesburg | Illinois | 61401 | — |
| Cedar Valley Med Specialists | Waterloo | Iowa | 50702 | — |
| Kentuckiana Cancer Institute | Louisville | Kentucky | 40202 | — |
| Minnesota Oncology Hematology, | Minneapolis | Minnesota | 55404 | — |
| Missouri Cancer Associates | Columbia | Missouri | 65201 | — |
| Kansas City Cancer Center, LLC | Lee's Summit | Missouri | 64064 | — |
| St. Louis Cancer & Breast Inst | St Louis | Missouri | 63141 | — |
| St. Barnabas Health Care Sys | Livingston | New Jersey | 07039 | — |
| New York Oncology Hematology | Albany | New York | 12206 | — |
| Eastchester Center/Cancer Care | The Bronx | New York | 10469 | — |
| Carolinas Hem-Oncology Assoc | Charlotte | North Carolina | 28203 | — |
| Raleigh Hemotology & Oncology | Raleigh | North Carolina | 27607 | — |
| Midwestern Regional Med Center | Eugene | Oregon | 97401-8122 | — |
| Texas Oncology Cancer Center | Austin | Texas | 78731 | — |
| Texas Oncology, P.A. | Bedford | Texas | 76022 | — |
| Cancer Specialists of South Te | Corpus Christi | Texas | 78412 | — |
| US Oncology Research, Inc. | Dallas | Texas | 75204 | — |
| USO | Dallas | Texas | 75230-2510 | — |
| Texas Oncology, P.A. | Dallas | Texas | 75231-4400 | — |
| Sammons Cancer Center | Dallas | Texas | 75246 | — |
| El Paso Cancer Treatment Ctr | El Paso | Texas | 79915 | — |
| Texas Oncology PA | Fort Worth | Texas | 76104 | — |
| Texas Oncology, P.A. | Houston | Texas | 77024-2305 | — |
| US Oncology | Midland | Texas | 79701 | — |
| USO - Tyler Cancer Ctr | Tyler | Texas | 75702 | — |
| Waco Cancer Care & Research Ce | Waco | Texas | 76712 | — |
| Northern Utah Associates | Ogden | Utah | 84403 | — |
| Fairfax N Virginia Hem/Onc PC | Fairfax | Virginia | 22031 | — |
| Northwest Medical Specialties | Tacoma | Washington | 98405 | — |
| Northwest Cancer Specialists | Vancouver | Washington | 98684 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00509769, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 2, 2013 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00509769 live on ClinicalTrials.gov.